BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19479993)

  • 1. Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon.
    Santoro A; Pisanti S; Grimaldi C; Izzo AA; Borrelli F; Proto MC; Malfitano AM; Gazzerro P; Laezza C; Bifulco M
    Int J Cancer; 2009 Sep; 125(5):996-1003. PubMed ID: 19479993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.
    Ouyang G; Yao L; Ruan K; Song G; Mao Y; Bao S
    Cell Biol Int; 2009 Dec; 33(12):1237-44. PubMed ID: 19732843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
    Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
    Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium.
    Scaife RM
    Mol Cancer Ther; 2004 Oct; 3(10):1229-37. PubMed ID: 15486190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Aurora-B kinase activity by poly(ADP-ribosyl)ation in response to DNA damage.
    Monaco L; Kolthur-Seetharam U; Loury R; Murcia JM; de Murcia G; Sassone-Corsi P
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14244-8. PubMed ID: 16179389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells.
    Dai E; Zhang J; Zhang D; Yang L; Wang Y; Jiang X; Ye L; Li X; Liu H; Ma J; Jiang H
    Hepatogastroenterology; 2014 Oct; 61(135):2052-61. PubMed ID: 25713910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastrophe.
    Natarajan G; Ramalingam S; Ramachandran I; May R; Queimado L; Houchen CW; Anant S
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1235-44. PubMed ID: 18325984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.
    Jin S; Tong T; Fan W; Fan F; Antinore MJ; Zhu X; Mazzacurati L; Li X; Petrik KL; Rajasekaran B; Wu M; Zhan Q
    Oncogene; 2002 Dec; 21(57):8696-704. PubMed ID: 12483522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.
    Malfitano AM; Laezza C; Galgani M; Matarese G; D'Alessandro A; Gazzerro P; Bifulco M
    Pharmacol Res; 2012 Mar; 65(3):365-71. PubMed ID: 22123497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
    Kuo PL; Chen CY; Hsu YL
    Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
    Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
    Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
    Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
    Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
    Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
    Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage.
    Blakemore LM; Boes C; Cordell R; Manson MM
    Carcinogenesis; 2013 Feb; 34(2):351-60. PubMed ID: 23125222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective control of mitotic and post-mitotic checkpoints in poly(ADP-ribose) polymerase-1(-/-) fibroblasts after mitotic spindle disruption.
    Halappanavar SS; Shah GM
    Cell Cycle; 2004 Mar; 3(3):335-42. PubMed ID: 14726664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cadmium-induced DNA damage triggers G(2)/M arrest via chk1/2 and cdc2 in p53-deficient kidney proximal tubule cells.
    Bork U; Lee WK; Kuchler A; Dittmar T; Thévenod F
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F255-65. PubMed ID: 19923412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.
    Sarnataro D; Pisanti S; Santoro A; Gazzerro P; Malfitano AM; Laezza C; Bifulco M
    Mol Pharmacol; 2006 Oct; 70(4):1298-306. PubMed ID: 16822929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
    Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
    Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer.
    Wang J; Gu Q; Li M; Zhang W; Yang M; Zou B; Chan S; Qiao L; Jiang B; Tu S; Ma J; Hung IF; Lan HY; Wong BC
    Carcinogenesis; 2009 Sep; 30(9):1507-16. PubMed ID: 19628579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints.
    Sabisz M; Wesierska-Gadek J; Skladanowski A
    Biochem Pharmacol; 2010 May; 79(10):1387-97. PubMed ID: 20067769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.